ETON Reports $21.3M Q4 Sales (+83% YoY), $0.06 GAAP EPS, Launches DESMODA, Licenses HEMANGEOL, Projects $110M+ 2026 Revenue, 30%+ Adjusted EBITDA Margin
Eton Pharmaceutcials, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $28.68
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS